Cancer drugs operate through various mechanisms to inhibit the growth of cancer cells. Some chemotherapeutic agents target rapidly dividing cells, while others interfere with specific cellular pathways involved in tumor progression. Targeted therapies aim at specific molecules involved in cancer cell growth, and immunotherapies enhance the body's immune response against cancer cells. Each mechanism comes with a unique toxicological profile that needs to be carefully managed.
